SEC Filing Summary: SPACEHAB, Incorporated (Form 8-K)
Business Context and Reporting Period
This Current Report on Form 8-K was filed by SPACEHAB, Incorporated on July 13, 2005. The filing addresses a material definitive agreement regarding the company's poison pill defense mechanism (Rights Agreement).
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and securities structure rather than financial performance.
Material Changes
- Termination of Rights Agreement: On July 13, 2005, the Company entered into an amendment to its Amended and Restated Rights Agreement (dated February 23, 2004).
- Expiration Acceleration: The amendment accelerated the expiration date of the Rights Agreement from April 9, 2009, to July 13, 2005.
- Effective Termination: The Rights Agreement, which issued rights to purchase Series A Junior Participating Preferred Stock to common stockholders, was terminated effective July 13, 2005.
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, management commentary on future operations, or specific risk factors beyond the structural change to shareholder rights. The removal of the Rights Agreement eliminates the specific anti-takeover provisions associated with the Series A Junior Participating Preferred Stock rights.
Investor Verification Checklist
- Confirm the effective date of the Rights Agreement termination (July 13, 2005).
- Verify the status of outstanding rights to purchase Series A Junior Participating Preferred Stock.
- Review the attached press release (Exhibit 99.1) for management's rationale regarding the termination.
- Check subsequent filings for any new shareholder rights plans or defensive measures.